This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Nitromed, Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Tatiana E Shelekhin: Innovator in Cannabinoid Research
Introduction
Tatiana E Shelekhin is a notable inventor based in the United States. She has made significant contributions to the field of cannabinoid research, focusing on the development of novel compounds that can modulate cannabinoid receptors. Her work aims to address various medical conditions associated with these receptors.
Latest Patents
Tatiana E Shelekhin holds a patent for "Substituted Imidazoheterocycles." This invention provides substituted imidazoheterocyclic compounds that have the potential to be used as modulators of cannabinoid receptors. The compounds are also useful for the prophylaxis and treatment of cannabinoid receptor-associated diseases and conditions, such as pain, inflammation, and pruritis.
Career Highlights
Tatiana is currently employed at Cara Therapeutics, Inc., where she continues her research and development efforts. Her innovative work in the pharmaceutical field has the potential to lead to new treatments for patients suffering from various ailments.
Collaborations
Tatiana has collaborated with notable colleagues, including R Paul Beckett and Richard Foster. These partnerships have contributed to her research and the advancement of cannabinoid-related therapies.
Conclusion
Tatiana E Shelekhin is a pioneering inventor whose work in cannabinoid research holds promise for the future of medical treatments. Her contributions to the field are significant and reflect her dedication to improving patient care through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile